From: Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy
Drugs
Number
Interferon
15
Somatostatin-analogues
2
EP, EC
16
CAV
3
TC, TP, DP, DC
4
VIP
6
Adriamycin+streptozotocin
FOLFOX, XELOX
FP, FC
IP
1
5-FU+adriamycin+streptozocin
Dacarbazine
Sunitinib
5
RAD001
Total
66